Searched for
US TARIFF ON INDIAN PHARMA
Trump announces new generic drugs tariff plan: No tariffs for 2 years, then 100%, and then 200%For Indian exporters, the two-year tariff-free period offers additional time to reassess supply chains and investment plans. While the imme...- Trump's Generic Drug Tariffs Explained: What it means for Indian pharma before the 200% stormTrump's generic drug tariffs plan provides Indian drugmakers a two-year duty-free window. This allows companies time to reassess manufactur...
- Why is market falling today? 7 factors behind Sensex's 700-point fall, Rs 4 lakh crore wealth wipeoutIndian stock markets experienced a decline on Wednesday as tensions in the Middle East escalated. Crude oil prices surged above $92 a barre...
- Sun Pharma, Cipla & other pharma stocks shed over 2% as Trump announces up to 200% tariffs on generic drugs from 2028Pharma stocks, including Sun Pharma, Cipla, Lupin and Dr Reddy's, fell up to 2.5% after US President Donald Trump announced a phased tariff...
- Trump tariffs may stay alive as US set to impose new import taxes by FridayDonald Trump is likely planning new import duties on many nations by Friday. These levies aim to continue his tariff regime after current o...
- Trump approves nuclear agreement that may allow Saudi Arabia to enrich uraniumPresident Trump approved a Saudi nuclear deal potentially granting enrichment capability. This agreement, lasting thirty years, involves U....
- Parliament Watch: FM on rupee, `16.1 lakh cr fuel taxes, India-US trade talks and moreRupee depreciation is influenced by rising crude oil prices and reduced capital account support. India monitors US trade policy changes and...
- India engaged with the US, studying all the developments: Govt tells ParliamentThe government told Parliament it is closely monitoring developments in its trade relationship with the US and remains engaged with Washing...
- Tariff policy wildly successful, more coming: USTR Jamieson GreerUS Trade Representative Jamieson Greer believes tariff measures reduced trade deficits and encouraged business reshoring. The Trump adminis...
- US imposes new 50% tariffs on a wide range of Canadian productsThe United States is imposing a 50% tariff on many Canadian goods. This follows Canada's alleged discriminatory treatment of American cars ...
- Natco Pharma shares surge 5% after US FDA's tentative nod Olaparib tabletsNatco Pharma shares rose sharply on Monday after the U.S. FDA granted tentative approval for its generic Olaparib tablets, a bioequivalent ...
- Trump seeks damages from Canada over wildfire smoke, revives tariff threatPresident Donald Trump spoke with Canadian Prime Minister Mark Carney about wildfire smoke. He suggested Canada should pay damages for the ...
- Alembic Pharma partner NATCO gets USFDA tentative nod for generic Olaparib tablets; US market size at USD 1.4 bnAlembic Pharmaceuticals and NATCO Pharma received tentative USFDA approval for generic Olaparib tablets. This approval is for a cancer drug...
- India watches as US bill targets buyers of Russian oil selectivelyIndia monitors a US bill proposing 100% tariffs on Russian oil imports. This legislation exempts European Union LNG and US uranium purchase...
- Pharma exports to UK may rise up to 10% in FY27 as CETA takes effectIndia's pharmaceutical exports to the UK are set to witness substantial growth thanks to the recently negotiated Comprehensive Economic and...
- India-UK FTA projected to boost Indian pharma exports by over 8% to $981 million in FY27: PharmexcilIndian pharmaceutical exports to the United Kingdom are projected to grow significantly. The India-UK Comprehensive Economic and Trade Agre...
- US says Brazil's tariff concessions favour India, Mexico in 301 probeThe United States Trade Representative announced tariffs on certain Brazilian imports. These tariffs target Brazil's preferential trade arr...
- FTAs alone won’t make India a manufacturing power: GTRI’s Ajay SrivastavaTariff concessions alone will not secure India’s long-term economic success; strengthening manufacturing competitiveness is the key, says A...
- An emboldened India holds out for better terms in US trade talksIndia rejected a swift trade agreement with the United States, seeking more favorable terms. New Delhi's confidence stems from new trading ...
- India-UK FTA: Pharma industry flags regulatory priorities ahead of July 15 rolloutIndustry stakeholders expect stronger trade, investment, and research partnerships but say implementation clarity will determine the pact’s...
Load More
